Hemlibra and Seizures - a phase IV clinical study of FDA data

Summary:

Seizures is reported as a side effect among people who take Hemlibra (emicizumab), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Epidiolex, and have Joint pain.

The phase IV clinical study analyzes which people have Seizures when taking Hemlibra. It is created by eHealthMe based on reports of 6,078 people who have side effects when taking Hemlibra from the FDA, and is updated regularly.

What is Hemlibra?

Hemlibra has active ingredients of emicizumab. eHealthMe is studying from 6,078 Hemlibra users. Check the latest studies of Hemlibra.

What is Seizures?

Seizures (abnormal excessive or synchronous neuronal activity in the brain) is found to be associated with 1,994 drugs and 2,278 conditions by eHealthMe. Check the latest studies of Seizures.



On Jul, 19, 2026

6,078 people reported to have side effects when taking Hemlibra.
Among them, 34 people (0.56%) have Seizures.

Could Hemlibra cause Seizures?

Among these 34 people:

How long have people been on Hemlibra when they have Seizures? *

  • < 1 month: 50 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 50 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Seizures when taking Hemlibra? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Seizures when taking Hemlibra? *

  • 0-1: 10 %
  • 2-9: 30 %
  • 10-19: 20 %
  • 20-29: 25 %
  • 30-39: 10 %
  • 40-49: 5 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Hemlibra? *

  1. Prednisone: 1 person, 2.94%
  2. Keppra: 1 person, 2.94%
  3. Epidiolex: 1 person, 2.94%

What are other side effects people have besides Seizures? *

  1. Fall: 7 people, 20.59%
  2. Haemorrhage (bleeding): 4 people, 11.76%
  3. Head Injury: 3 people, 8.82%
  4. Haematuria (presence of blood in urine): 2 people, 5.88%
  5. Injury: 2 people, 5.88%
  6. Subdural Haemorrhage (bleeding between the skull and the surface of the brain): 2 people, 5.88%
  7. Ligament Sprain (ligament stretched): 2 people, 5.88%
  8. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 2.94%
  9. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 2.94%
  10. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 2.94%

What are the existing conditions these people have? *

  1. Joint Pain: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Hemlibra and have Seizures?

- Check whether Seizures is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hemlibra:

Seizures treatments and more:

How severe was Seizures and when was it recovered:

Expand to all the drugs that have ingredients of emicizumab:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hemlibra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seizures:

Browse all the conditions that are associated with Seizures:


How the study uses the data?

The study uses data from the FDA. It is based on emicizumab (the active ingredients of Hemlibra) and Hemlibra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: